Literature DB >> 15846376

Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.

Y Kfoury1, R Nasr, O Hermine, H de Thé, A Bazarbachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15846376     DOI： 10.1038/sj.cdd.4401624

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  18 in total

1.  The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.

Authors:  Leon Bernal-Mizrachi; Christine M Lovly; Lee Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-02       Impact factor: 11.205

Review 2.  HTLV-1 p13, a small protein with a busy agenda.

Authors:  Micol Silic-Benussi; Roberta Biasiotto; Vibeke Andresen; Genoveffa Franchini; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Mol Aspects Med       Date:  2010-03-21

3.  Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?

Authors:  Marie-Olivia Chandesris; David Ghez; Caroline Besson; Felipe Suarez; Richard Delarue; Marie-Thérèse Rubio; Ali Bazarbachi; Bruno Varet; Olivier Hermine
Journal:  BMJ Case Rep       Date:  2009-08-10

4.  NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.

Authors:  Ishraq Hussain; Ikbal Fathallah; Rosita Accardi; Jiping Yue; Djamel Saidj; Ruchi Shukla; Uzma Hasan; Tarik Gheit; Yamei Niu; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma.

Authors:  Andrew Hsu; Kelsey E Huntington; Andre De Souza; Lanlan Zhou; Adam J Olszewski; Nirav P Makwana; Diana O Treaba; Ludimila Cavalcante; Francis J Giles; Howard Safran; Wafik S El-Deiry; Benedito A Carneiro
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

Review 6.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

Review 7.  Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?

Authors:  Rihab Nasr; Hiba El Hajj; Youmna Kfoury; Hugues de Thé; Olivier Hermine; Ali Bazarbachi
Journal:  Viruses       Date:  2011-06-14       Impact factor: 5.048

8.  Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.

Authors:  Emmanuel Agbottah; Wen-I Yeh; Reem Berro; Zachary Klase; Caitlin Pedati; Kyleen Kehn-Hall; Weilin Wu; Fatah Kashanchi
Journal:  AIDS Res Ther       Date:  2008-06-10       Impact factor: 2.250

9.  Animal models on HTLV-1 and related viruses: what did we learn?

Authors:  Hiba El Hajj; Rihab Nasr; Youmna Kfoury; Zeina Dassouki; Roudaina Nasser; Ghada Kchour; Olivier Hermine; Hugues de Thé; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2012-09-21       Impact factor: 5.640

10.  Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation.

Authors:  Margret Shirinian; Youmna Kfoury; Zeina Dassouki; Hiba El-Hajj; Ali Bazarbachi
Journal:  Front Microbiol       Date:  2013-08-15       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.